TK1 and pancreatic ductal adenocarcinoma: Silencing of TK1 decreased cell proliferation in vitro and in vivo in pancreatic ductal adenocarcinoma (PDAC) cell lines suggesting the exploitation of TK1 not just as a biomarker but also as a potential anti-cancer target (Figure 2C) [82].